Population genetics, sequence diversity and selection in the gene encoding the Plasmodium falciparum apical membrane antigen 1 in clinical isolates from the south-east of Iran

Infection, Genetics and Evolution

Volumn 17, Issue , 2013, Pages 51-61

  Mehrizi, Akram Abouie ^a   Sepehri, Masoumeh ^b   Karimi, Fatemeh ^a   Djadid, Navid Dinparast ^a   Zakeri, Sedigheh ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Apical membrane antigen 1; Genetic diversity; Iran; Plasmodium falciparum; Vaccine

Indexed keywords

APICAL MEMBRANE ANTIGEN 1;

APICAL MEMBRANE ANTIGEN 1 GENE; ARTICLE; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC CODE; GENETIC DIFFERENCE; GENETIC RECOMBINATION; GENETIC SELECTION; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; IRAN; MOLECULAR MODEL; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PURIFYING SELECTION; RESIDUE ANALYSIS; SEASONAL VARIATION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ANALYSIS; UNINDEXED SEQUENCE;

AMINO ACID SEQUENCE; ANTIGENS, PROTOZOAN; EPITOPES, B-LYMPHOCYTE; EVOLUTION, MOLECULAR; GENE FREQUENCY; GENETIC VARIATION; HAPLOTYPES; HUMANS; IRAN; MALARIA VACCINES; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; RECOMBINATION, GENETIC; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA;

PLASMODIUM FALCIPARUM;

EID: 84876742844     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.03.042     Document Type: Article

References (79)

1. Alonso P.L., Brown G., Arevalo-Herrera M., Binka F., Chitnis C., Collins F., Doumbo O.K., Greenwood B., Hall B.F., Levine M.M., Mendis K., Newman R.D., Plowe C.V., Rodríguez M.H., Sinden R., Slutsker L., Tanner M. A research agenda to underpin malaria eradication. PLoS. Med. 2011, 8:e1000406.
2. Anderson T.J., Haubold B., Williams J.T., Estrada-Franco J.G., Richardson L., Mollinedo R., Bockarie M., Mokili J., Mharakurwa S., French N., Whitworth J., Velez I.D.A., Brockman H., Nosten F., Ferreira M.U., Day K.P. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol. Biol. Evol. 2000, 17:1467-1482.
3. Anstey N.M., Russell B., Yeo T.W., Price R.N. The pathophysiology of vivax malaria. Trends Parasitol. 2009, 25:220-227.
4. Bai T., Becker M., Gupta A., Strike P., Murphy V.J., Anders R.F., Batchelor A.H. Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc. Natl. Acad. Sci. USA 2005, 102:12736-12741.
5. Balloux F., Lugon-Moulin N. The estimation of population differentiation with microsatellite markers. Mol. Ecol. 2002, 11:155-165.
6. Biswas S., Dicks M.D.J., Long C.A., Remarque E.J., Siani L., et al. Transgene Optimization, Immunogenicity and in vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1. PLoS One 2011, 6(6):e20977. 10.1371/journal.pone.0020977.
7. Bueno L.L., Lobo F.P., Morais C.G., Mourão L.C., de Ávila R.A., Soares I.S., Fontes C.J., Lacerda M.V., Chavez Olórtegui C., Bartholomeu D.C., Fujiwara R.T., Braga E.M. Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1). PLoS One 2011, 6:e21289.
8. Cheng Q., Saul A. Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax. Mol. Biochem. Parasitol. 1994, 65:183-187.
9. Chesne-Seck M.L., Pizarro J.C., Vulliez-Le Normand B., Collins C.R., Blackman M.J., Faber B.W., Remarque E.J., Kocken C.H., Thomas A.W., Bentley G.A. Structural comparison of apical membrane antigen1 orthologues and paralogues in apicomplexan parasites. Mol. Biochem. Parasitol. 2005, 144:55-67.
10. Coley A.M., Campanale N.V., Casey J.L., Hodder A.N., Crewther P.E., Anders R.F., Tilley L.M., Foley M. Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides. Protein Eng. 2001, 14:691-698.
11. Coley A.M., Parisi K., Masciantonio R., Hoeck J., Casey J.L., Murphy V.J., Harris K.S., Batchelor A.H., Anders R.F., Foley M. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. Infect. Immun. 2006, 74:2628-2636.
12. Coley A.M., Gupta A., Murphy V.J., Bai T., Kim H., Foley M., Anders R.F., Batchelor A.H. Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. PLoS Pathog. 2007, 3:1308-1319.
13. Collins C.R., Withers-Martinez C., Bentley G.A., Batchelor A.H., Thomas A.W., Blackman M.J. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen1. J. Biol. Chem. 2007, 282:7431-7441.
14. Cortés A., Mellombo M., Mueller I., Benet A., Reeder J.C., Anders R.F. Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1. Infect. Immun. 2003, 71:1416-1426.
15. Crewther P.E., Matthew M.L., Flegg R.H., Anders R.F. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 1996, 64:3310-3317.
16. Dondorp A.M., Fairhurst R.M., Slutsker L., Macarthur J.R., Breman J.G., Guerin P.J., Wellems T.E., Ringwald P., Newman R.D., Plowe C.V. The threat of artemisinin-resistant malaria. N. Engl. J. Med. 2011, 365:1073-1075.
17. Dutta S., Lee S.Y., Batchelor A.H., Lanar D.E. Structural basis of antigenic escape of a malaria vaccine candidate. Proc. Natl. Acad. Sci. USA 2007, 104:12488-12493.
18. Dutta S., Sullivan J.S., Grady K.K., Haynes J.D., Komisar J., Batchelor A.H., Soisson L., Diggs C.L., Heppner D.G., Lanar D.E., Collins W.E., Barnwell J.W. High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model. PLoS One 2009, 4:e8138.
19. Eisen D.P., Marshall V.M., Billman-Jacobe H., Coppel R.L. A Plasmodium falciparum apical membrane antigen-1 (AMA-1) gene apparently generated by intragenic recombination. Mol. Biochem. Parasitol. 1999, 100:243-246.
20. Escalante A.A., Grebert H.M., Chaiyaroj S.C., Magris M., Biswas S., Nahlen B.L., Lal A.A. Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort project. Mol. Biochem. Parasitol. 2001, 113:279-287.
21. Feng Z.P., Keizer D.W., Stevenson R.A., Yao S., Babon J.J., Murphy V.J., Anders R.F., Norton R.S. Structure and inter-domain interactions of domain II from the blood-stage malarial protein, apical membrane antigen 1. J. Mol. Biol. 2005, 350:641-656.
22. Figtree M., Pasay C.J., Slade R., Cheng Q., Cloonan N., Walker J., Saul A. Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA-1 and MSP-1 genes. Mol. Biochem. Parasitol. 2000, 108:53-66.
23. Fu Y.X., Li W.H. Statistical tests of neutrality of mutations. Genetics 1993, 133:693-709.
24. Garg S., Alam M.T., Das M.K., Dev V., Kumar A., Dash A.P., Sharma Y.D. Sequence diversity and natural selection at domain I of the apical membrane antigen 1 among Indian Plasmodium falciparum populations. Malar. J. 2007, 22(6):154.
25. Genton B., Reed Z.H. Asexual blood-stage malaria vaccine development: facing the challenges. Curr. Opin. Infect. Dis. 2007, 20:467-475.
26. Girard M.P., Reed Z.H., Friede M., Kieny M.P. A review of human vaccine research and development: malaria. Vaccine 2007, 25:1567-1580.
27. Gunasekera A.M., Wickramarachchi T., Neafsey D.E., Ganguli I., Perera L., Premaratne P.H., Hartl D., Handunnetti S.M., Udagama-Randeniya P.V., Wirth D.F. Genetic diversity and selection at the Plasmodium vivax apical membrane antigen-1 (PvAMA-1) locus in a Sri Lankan population. Mol. Biol. Evol. 2007, 24:939-947.
28. Healer J., Murphy V., Hodder A.N., Masciantonio R., Gemmill A.W., Anders R.F., Cowman A.F., Batchelor A. Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum. Mol. Microbiol. 2004, 52:159-168.
29. Herrera S., Corradin G., Arévalo-Herrera M. An update on the search for a Plasmodium vivax vaccine. Trends Parasitol. 2007, 23:122-128.
30. Hodder A.N., Crewther P.E., Anders R.F. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 2001, 69:3286-3294.
31. Hoffmann E.H., da Silveira L.A., Tonhosolo R., Pereira F.J., Ribeiro W.L., Tonon A.P., Kawamoto F., Ferreira M.U. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2. Ann. Trop. Med. Parasitol. 2001, 95:117-132.
32. Howell S.A., Withers-Martinez C., Kocken C.H., Thomas A.W., Blackman M.J. Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J. Biol. Chem. 2001, 276:31311-31320.
33. Igonet S., Vulliez-Le Normand B., Faure G., Riottot M.M., Kocken C.H., Thomas A.W., Bentley G.A. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterization. J. Mol. Biol. 2007, 366:1523-1537.
34. Jukes T.H., Cantor R.C. Evolution of protein molecules. Mammalian Protein Metabolism 1969, 21-132. Academic Press, New York. H.N. Munro (Ed.).
35. Kennedy M.C., Wang J., Zhang Y., Miles A.P., Chitsaz F., Saul A., Long C.A., Miller L.H., Stowers A.W. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 2002, 70:6948-6960.
36. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 1980, 16:111-120.
37. Kocken C.H., van der Wel A.M., Dubbeld M.A., Narum D.L., van de Rijke F.M., van Gemert G.J., van der Linde X., Bannister L.H., Janse C., Waters A.P., Thomas A.W. Precisetiming of expression of a Plasmodium falciparum-derived transgene in Plasmodium berghei is a critical determinant of subsequent subcellular localization. J. Biol. Chem. 1998, 273:15119-15124.
38. Kocken C.H., Narum1 D.L., Massougbodji A., Ayivi B., Dubbeld M.A., van der Wel A., Conway D.J., Sanni A., Thomas A.W. Molecular characterization of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion. Mol. Biochem. Parasitol. 2000, 109:147-156.
39. Kusi K.A., Faber B.W., Thomas A.W., Remarque E.J. Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity. PLoS One 2009, 4:e8110.
40. Kusi K.A., Remarque E.J., Riasat V., Walraven V., Thomas A.W., Faber B.W., Kocken C.H. Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques. Malar. J. 2011, 4(10):182.
41. Lalitha P.V., Ware L.A., Barbosa A., Dutta S., Moch J.K., Haynes J.D., Fileta B.B., White C.E., Lanar D.E. Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1ectodomain and analysis of the immune response. Infect. Immun. 2004, 72:4464-4470.
42. Langermans J.A., Hensmann M., van Gijlswiik M., Zhang D., Pan W., Giersing B.K., Locke E., Dubovsk F., Wittes J., Thomas A.W. Preclinical evaluation of a chimeric malaria vaccine candidate in Montanide ISA 720: immunogenicity and safety in rhesus macaques. Hum. Vaccin. 2006, 2:222-226.
43. Librado P., Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 2009, 25:1451-1452.
44. malERA Consultative Group on Vaccines A research agenda for malaria eradication: vaccines. PLoS Med. 2011, 8:e1000398.
45. Malkin E.M., Diemert D.J., McArthur J.H., Perreault J.R., Miles A.P., Giersing B.K., Mullen G.E., Orcutt A., Muratova O., Awkal M., Zhou H., Wang J., Stowers A., Long C.A., Mahanty S., Miller L.H., Saul A., Durbin A.P. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect. Immun. 2005, 73:3677-3685.
46. Mardani A., Keshavarz H., Heidari A., Hajjaran H., Raeisi A., Khorramizadeh M.R. Genetic diversity and natural selection at the domain I of apical membrane antigen-1 (AMA-1) of Plasmodium falciparum in isolates from Iran. Exp. Parasitol. 2012, 130:456-462.
47. McDonald J.H., Kreitman M. Adaptive protein evolution at the Adh locus in Drosophila. Nature 1991, 351:652-654.
48. Miao J., Li X., Liu Z., Xue C., Bujard H., Cui L. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines. Vaccine 2006, 24:6187-6198.
49. Miura K., Zhou H., Muratova O.V., Orcutt A.C., Giersing B., Miller L.H., Long C.A. In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized. Infect. Immun. 2007, 75:5827-5836.
50. Moon S.U., Na B.K., Kang J.M., Kim J.Y., Cho S.H., Park Y.K., Sohn W.M., Lin K., Kim T.S. Genetic polymorphism and effect of natural selection at domain I of apical membrane antigen-1 (AMA-1) in Plasmodium vivax isolates from Myanmar. Acta. Trop. 2010, 114:71-75.
51. Mu J., Awadalla P., Duan J., McGee K.M., Joy D.A., McVean G.A., Su X.Z. Recombination hotspots and population structure in Plasmodium falciparum. PLoS Biol. 2005, 3:e335.
52. Nair M., Hinds M.G., Coley A.M., Hodder A.N., Foley M., Anders R.F., Norton R.S. Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1). J. Mol. Biol. 2002, 322:741-753.
53. Nei M., Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 1986, 3:418-426.
54. Ord R.L., Tami A., Sutherland C.J. Ama 1 genes of sympatric Plasmodium vivax and P falciparum from Venezuela differ significantly in genetic diversity and recombination frequency. PLoS One 2008, 3:e3366.
55. Osier F.H., Weedall G.D., Verra F., Murungi L., Tetteh K.K., Bull P., Faber B.W., Remarque E., Thomas A., Marsh K., Conway D.J. Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya. Infect. Immun. 2010, 8:4625-4633.
56. Peterson M.G., Marshall V.M., Smythe J.A., Crewther P.E., Lew A., Silva A., Anders R.F., Kemp D.J. Integral membrane protein located in the apical complex of Plasmodium falciparum. Mol. Cell. Biol. 1989, 9:3151-3154.
57. Pizarro J.C., Vulliez-Le Normand B., Chesne-Seck M.L., Collins C.R., Withers-Martinez C., Hackett F., Blackman M.J., Faber B.W., Remarque E.J., Kocken C.H., Thomas A.W., Bentley G.A. Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science 2005, 308:408-411.
58. Polley S.D., Conway D.J. Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen1 gene. Genetics 2001, 158:1505-1512.
59. Polley S.D., Chokejindachai W., Conway D.J. Allele frequency-based analyses robustly map sequence site under balancing selection in a malaria vaccine candidate antigen. Genetics 2003, 165:555-561.
60. Putaporntip C., Jongwutiwes S., Grynberg P., Cui L., Hughes A.L. Nucleotide sequence polymorphism at the apical membrane antigen-1 locus reveals population history of Plasmodium vivax in Thailand. Infect. Genet. Evol. 2009, 9:1295-1300.
61. Rajesh V., Singamsetti V.K., Vidya S., Gowrishankar M., Elamaran M., Tripathi J., Radhika N.B., Kochar D., Ranjan A., Roy S.K., Das A. Plasmodium falciparum: genetic polymorphism in apical membrane antigen-1 gene from Indian isolates. Exp. Parasitol. 2008, 119:144-151.
62. Rand D.M., Kann L.M. Excess amino acid polymorphism in mitochondrial DNA: contrasts among genes from Drosophila, mice, and humans. Mol. Biol. Evol. 1996, 13:735-748.
63. Remarque E.J., Faber B.W., Kocken C.H., Thomas A.W. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. Infect. Immun. 2008, 76:2660-2670.
64. Saul A., Lawrence G., Allworth A., Elliott S., Anderson K., Rzepczyk C., Martin L.B., Taylor D., Eisen D.P., Irving D.O., Pye D., Crewther P.E., Hodder A.N., Murphy V.J., Anders R.F. A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant. Vaccine 2005, 23:3076-3083.
65. Schoepflin S., Valsangiacomo F., Lin E., Kiniboro B., Mueller I., Felger I. Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping. Malar. J. 2009, 8:250.
66. Snounou G., Viriyakosol S., Zhu X.P., Jarra W., Pinheiro L., do Rosario V.E., Thaithong S., Brown K.N. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 1993, 61:315-320.
67. Stowers A.W., Kennedy M.C., Keegan B.P., Saul A., Long C.A., Miller L.H. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria. Infect. Immun. 2002, 70:6961-6967.
68. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989, 123:585-595.
69. Takala S.L., Coulibaly D., Thera M.A., Batchelor A.H., Cummings M.P., Escalante A.A., Ouattara A., Traoré K., Niangaly A., Djimdé A.A., Doumbo O.K., Plowe C.V. Extreme polymorphism in a vaccine antigen and risk of clinical malaria implications for vaccine development. Sci. Trans. Med. 2009, 1:25.
70. Tetteh K.K., Stewart L.B., Ochola L.I., Amambua-Ngwa A., Thomas A.W., Marsh K., Weedall G.D., Conway D.J. Prospective identification of malaria parasite genes under balancing selection. PLoS One 2009, 4:e5568.
71. Trape J.F., Tall A., Diagne N., Ndiath O., Ly A.B., Faye J., Dieye-Ba F., Roucher C., Bouganali C., Badiane A., Sarr F.D., Mazenot C., Touré-Baldé A., Raoult D., Druilhe P., Mercereau-Puijalon O., Rogier C., Sokhna C. Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bed nets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect. Dis. 2011, 11:925-932.
72. Urquiza M., Suarez J.E., Cardenas C., Lopez R., Puentes A., Chavez F., Calvo J.C., Patarroyo M.E. Plasmodium falciparum AMA-1 erythrocyte binding peptide simplicate AMA-1 as erythrocyte binding protein. Vaccine 2000, 19:508-513.
73. Verra F., Hughes A.L. Evidence for ancient balanced polymorphism at the Apical Membrane Antigen-1 (AMA-1) locus of Plasmodium falciparum. Mol. Biochem. Parasitol. 2000, 105:149-153.
74. Volkman S.K., Ndiaye D., Diakite M., Koita O.A., Nwakanma D., Daniels R.F., Park D.J., Neafsey D.E., Muskavitch M.A., Krogstad D.J., Sabeti P.C., Hartl D.L., Wirth D.F. Application of genomics to field investigations of malaria by the international centers of excellence for malaria research. Acta Trop. 2012, 121:324-332.
75. Waters A.P., Thomas A.W., Deans J.A., Mitchell G.H., Hudson D.E., Miller L.H., McCutchan T.F., Cohen S. A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium. J. Biol. Chem. 1990, 265:17974-17979.
76. WHO report, 2012: http://www.who.int/mediacentre/factsheets/fs094/en/index.html.
77. Wykes M., Good M.F. A case for whole-parasite malaria vaccines. Int. J. Parasitol. 2007, 37:705-712.
78. Zakeri S., Kakar Q., Ghasemi F., Raeisi A., Butt W., Safi N., Afsharpad M., Memon M.S., Gholizadeh S., Salehi M., Atta H., Zamani G., Djadid N.D. Detection of mixed Plasmodium falciparum & P. vivax infections by nested-PCR in Pakistan, Iran & Afghanistan. Indian. J. Med. Res. 2010, 132:31-35.
79. Zakeri S., Sadeghi H., Mehrizi A.A., Djadid N.D. Population genetic structure and polymorphism analysis of gene encoding apical membrane antigen-1(AMA-1) of Iranian Plasmodium vivax wild isolates. Acta Trop. 2013, 126:269-279.